Human Gene TherapyVol. 33, No. 13-14 Pathways/InterviewTalking Regulation: An Interview with Peter Marks, MD/PhDThomas GallagherThomas Gallagher*Correspondence: Dr. Thomas Gallagher, Managing Editor, Human Gene Therapy, Mary Ann Liebert, Inc., New Rochelle, NY 10801, USA. E-mail Address: hgt_eo@liebertpub.comManaging Editor, Human Gene Therapy.Search for more papers by this authorPublished Online:13 Jul 2022https://doi.org/10.1089/hum.2022.29213.intAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 13-14Jul 2022 InformationCopyright 2022, by Mary Ann Liebert, Inc., publishersTo cite this article:Thomas Gallagher.Talking Regulation: An Interview with Peter Marks, MD/PhD.Human Gene Therapy.Jul 2022.689-691.http://doi.org/10.1089/hum.2022.29213.intPublished in Volume: 33 Issue 13-14: July 13, 2022PDF download

Human Gene TherapyVol. 33, No. 23-24 Meeting SummaryMeeting Summary: ESGCT 2022 AAV Safety Plenary SessionThomas GallagherThomas Gallagher*Correspondence: E-mail Address: hgt_eo@liebertpub.comManaging Editor, Human Gene Therapy, Mary Ann Liebert, Inc. New Rochelle, New York, USA.Search for more papers by this authorPublished Online:14 Dec 2022https://doi.org/10.1089/hum.2022.29230.tgaAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 23-24Dec 2022 InformationCopyright 2022, by Mary Ann Liebert, Inc., publishersTo cite this article:Thomas Gallagher.Meeting Summary: ESGCT 2022 AAV Safety Plenary Session.Human Gene Therapy.Dec 2022.1217-1220.http://doi.org/10.1089/hum.2022.29230.tgaPublished in Volume: 33 Issue 23-24: December 14, 2022PDF download

Human Gene TherapyVol. 33, No. 7-8 InterviewInterview with Beverly Davidson, PhDThomas GallagherThomas Gallagher*Correspondence: Dr. Thomas Gallagher, Managing Editor, Human Gene Therapy, Mary Ann Liebert, Inc., New Rochelle, New York, NY 10801, USA. E-mail Address: HGT_EO@Liebertpub.comManaging Editor, Human Gene Therapy.Search for more papers by this authorPublished Online:19 Apr 2022https://doi.org/10.1089/hum.2022.29205.intAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 7-8Apr 2022 InformationCopyright 2022, by Mary Ann Liebert, Inc., publishersTo cite this article:Thomas Gallagher.Interview with Beverly Davidson, PhD.Human Gene Therapy.Apr 2022.347-350.http://doi.org/10.1089/hum.2022.29205.intPublished in Volume: 33 Issue 7-8: April 19, 2022PDF download

Human Gene TherapyVol. 33, No. 19-20 InterviewInterview with Dr. Ronald CrystalThomas GallagherThomas Gallagher*Correspondence: Dr. Thomas Gallagher, Managing Editor, Human Gene Therapy, Mary Ann Liebert, Inc., New Rochelle, NY 10801, USA. E-mail Address: hgt_eo@liebertpub.comManaging Editor, Human Gene Therapy.Search for more papers by this authorPublished Online:17 Oct 2022https://doi.org/10.1089/hum.2022.29221.intAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 19-20Oct 2022 InformationCopyright 2022, by Mary Ann Liebert, Inc., publishersTo cite this article:Thomas Gallagher.Interview with Dr. Ronald Crystal.Human Gene Therapy.Oct 2022.1003-1005.http://doi.org/10.1089/hum.2022.29221.intPublished in Volume: 33 Issue 19-20: October 17, 2022PDF download

Human Gene TherapyVol. 32, No. 17-18 Pathways/InterviewGene Therapy, the Immune System, and Vaccine Development: An Interview with Hildegund ErtlThomas GallagherThomas Gallagher*Correspondence: Dr. Thomas Gallagher, Managing Editor, Human Gene Therapy, Mary Ann Liebert, Inc., New Rochelle, New York, NY 10801, USA. E-mail Address: HGT_EO@Liebertpub.comManaging Editor, Human Gene Therapy.Search for more papers by this authorPublished Online:23 Sep 2021https://doi.org/10.1089/hum.2021.29177.herAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 32Issue 17-18Sep 2021 InformationCopyright 2021, by Mary Ann Liebert, Inc., publishersTo cite this article:Thomas Gallagher.Gene Therapy, the Immune System, and Vaccine Development: An Interview with Hildegund Ertl.Human Gene Therapy.Sep 2021.865-867.http://doi.org/10.1089/hum.2021.29177.herPublished in Volume: 32 Issue 17-18: September 23, 2021PDF download